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Project team roles and responsibilities
Work Programme
The present working programme will be applied to students of the Biology Laboratories (BL) curricular unit (CU). The 
programme starts on the 16th of October 2019 within a full semester. The programme will involve innovative learning 
methodologies, implementing the mission and vision of the Mission NERD (Nanotechnology Education and Research 
Demonstrations) project.
The phases envisaged for the work programme are listed below.
Phase 1
Provide a list of concepts to stimulate students in STEM education. The concepts will be in the scope of nanotechnology 
and biology, or other related topics.
For conceptual understanding, and team work building, the students will be divided in teams of 3-4 elements. They will 
design a strategy to decode science based on a:
simple experiment (hands-on);
digital narrative (communicating science);
pitch talk to the general public (the “art” of communication) following the vision of Mission NERD project.
Phase 2
Hands-on (laboratory work, implementation of an experiment based on recycling material, if possible.)
Phase 3
Digital narrative (3 minutes video)
Phase 4
Pitch talk and local engagement or experience (development of an inclusive description and methodology to engage 
general public). The students will identify a partner to present their concept to Mission NERD partners.
Estudantes
Cientistas Professores
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One-step trapping of droplets and surface
functionalization of sensors using gold-patterned
structures for multiplexing in biochips†
T. M. Dias, *abc E. Fernandes,d S. Cardoso,cd G. Monteirobc and P. P. Freitasad
Multiplexing in Point-of-Care (POC) diagnostics is crucial for a comprehensive readout of multifactorial
diseases such as cancer or fast-acting complications such as heart attacks. In multiplexed POC (MPOC)
testing, groups of sensors are functionalized with di!erent biological probes, enabling the simultaneous
capture and detection of various analytes. Current literature demonstrates MPOC systems using
micro"uidics, capable of compartmentalizing only a few sensing regions. In contrast, miniaturized
robotic spotting (microspotting) theoretically enables the independent functionalization of every sensor
in a microarray. However, its use is still challenging in biosensors which require the combination of
di!erent materials at the surface because microspotted droplets tend to move to areas of higher surface
energy, thus a!ecting the spotting precision. To counteract this phenomenon, we have combined
shapes of gold-patterned #lms for the functionalization of magnetoresistive (MR) sensors and
simultaneous trapping of droplets over the sensing regions, previously passivated with silicon nitride
(Si3N4). Due to the higher hydrophobicity of gold when compared to Si3N4, the droplets remain
immobilized inside the gold frames and functionalization of the sensors is accurately achieved. With this
strategy, we demonstrate the microspotting of di!erent DNA probes and antibodies and the speci#c
hybridization and binding of complementary DNA targets and proteins, attached to magnetic beads. This
combined trapping and functionalization system shows promise in the implementation of MR-based
systems in multiplexing applications. This work can also be of interest to the wider community working
in the development of other surface-based assays, also developed through microfabrication techniques,
as the same trapping methodology is conceivable for adaption to other biochip formats.
1. Introduction
The implementation of microsystems capable of multiple ana-
lyte detection from a single sample is gaining increased
importance at the Point-of-Care (POC). A recent review pub-
lished by Gerald A. Urban and co-workers broadly highlights the
importance of such systems in POC applications.1 In compar-
ison to tests performed in centralized laboratories, the use of
miniaturized POC systems enables on-the-spot testing where
the patient needs, rapid analysis, the use of a smaller volume of
reagents/samples which is, in general, associated with lower
costs.2,3
Because of these advantages, miniaturized POC systems are
gaining increased interest in applications where time is critical,
for instance, in the emergent triage of imminent diseases (e.g.
heart attacks);4 regions where laboratory facilities are nonexis-
tent and resources are low (e.g., developing countries);5 or as
a methodology for analysis of multifactorial diseases such as
cancer for rapid treatment decision.6 In most of complex
diseases, the diagnosis of a single biomarker does not provide
a de!nitive diagnostic and multiplexing approaches are
required.7
Several bio-sensing technologies can be adapted for this
purpose and many formats are available. Although some
exceptions exist, most of the sensor methodologies are broadly
classi!ed into label-based and label-free. In our group, we
research the potential implementation of magnetoresistive
(MR) sensors in bio-sensing applications. MR sensors detect
target entities when attached to magnetic nanoparticles (MNPs)
and are included in the classi!cation of label-based systems.8
When compared to traditional label-based technologies, usually
employing optical labels (e.g. colorimetric, "uorescent or
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A B S T R A C T
The excellent electronic properties of single-layer graphene provide the fundamental basis for its use in advanced
electronics applications. Graphene-based biosensors, however, are one of the exceptions among the applications
that take advantage of the unique properties of this material, because high hydrophobicity of graphene hinders
the controlled immobilization of biomolecular probes, particularly of antibodies for immunoassays. In contrast
to methods that rely on aggressive chemical oxidation of graphene, we overcome this challenge by implementing
an e!ective strategy that modi"es single-layer graphene to render it hydrophilic and biocompatible without
compromising the electronic structure. Graphene produced in-house by chemical vapor deposition (CVD) was
modi"ed with a heterobifunctional linker that attached to the surface via a pyrene group and presented a
standard N-hydroxysuccinimide (NHS) ester ligand for covalent immobilization of biomolecules. The suitability
of thus modi"ed surface for biofunctionalization was then con"rmed via real-time monitoring of the im-
mobilization of an antibody by quartz crystal microbalance (QCM) measurements followed by the chemical
characterization by x-ray photoelectron spectroscopy (XPS). Finally, as a proof-of-concept for biofunctionali-
zation of graphene without compromising its electronic structure, a graphene immuno-"eld-e!ect transistor
(immuno-FET) was fabricated, biofunctionalized, and tested for detection of Matrix Metalloproteinase 9 (MMP-
9), a biomarker related to clinical diagnostics of ischemic stroke.
1. Introduction
The unique fundamental properties of graphene [1], particularly the
chemical stability and extreme sensitivity to near-surface charges and
electric "elds, suggest its use for biomolecular detection [2–4]. The
hydrophobicity and high sensitivity to charges and electrical "elds,
however, result in strong interference from nonspeci"c molecular ad-
sorption and thus poor selectivity of unmodi"ed graphene sensors for
bioanalytes when operating in an aqueous physiological environment.
Accordingly, to produce selective and speci"c biosensors, graphene
surfaces need to be functionalized [5–7] with speci"c biomolecular
probes, thereby minimizing nonspeci"c adsorption and ensuring that
the surface binding events are dominated by the biorecognition of the
target. These molecular binding events can be e!ectively transduced
into electrical signals by using the functionalized single-layer graphene
as the channel of a "eld-e!ect transistor (FET), or more speci"cally for
biosensing, of an electrolyte-gated FET (EGFET) [5,8,9].
The most common graphene functionalization methods overcome
the hydrophobic nature of pristine graphene by oxidation treatments to
produce graphene oxide (GO) or reduced GO (rGO), followed by
covalent or non-covalent immobilization of biomolecular probes
[10–13]. The aggressive oxidation treatments, however, typically de-
stroy the excellent electronic properties of pristine graphene [14]. To
preserve the unique electronic structure of graphene for biosensing
applications, non-covalent (!-! stacking) modi"cation of pristine gra-
phene using pyrene derivatives as heterobifunctional linkers is a pop-
ular approach [5,9,15–19], for which the detailed mechanistic under-
standing is still emerging [20–24]. Reports on implementations of this
approach to date typically rely on the device performance [9,17–19] as
an indirect indicator of a successful surface functionalization, rather
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Nanoparticle administration 
method in cell culture alters 
particle-cell interaction
Thomas L. Moore  1, Dominic A. Urban1, Laura Rodriguez-Lorenzo1, Ana Milosevic1, 
Federica Crippa1, Miguel Spuch-Calvar1, Sandor Balog  1, Barbara Rothen-Rutishauser  1, 
Marco Lattuada2 & Alke Petri-Fink1,2
As a highly interdisciplinary field, working with nanoparticles in a biomedical context requires a robust 
understanding of soft matter physics, colloidal behaviors, nano-characterization methods, biology, 
and bio-nano interactions. When reporting results, it can be easy to overlook simple, seemingly trivial 
experimental details. In this context, we set out to understand how in vitro technique, specifically the 
way we administer particles in 2D culture, can influence experimental outcomes. Gold nanoparticles 
coated with poly(vinylpyrrolidone) were added to J774A.1 mouse monocyte/macrophage cultures 
as either a concentrated bolus, a bolus then mixed via aspiration, or pre-mixed in cell culture media. 
Particle-cell interaction was monitored via inductively coupled plasma-optical emission spectroscopy 
and we found that particles administered in a concentrated dose interacted more with cells compared 
to the pre-mixed administration method. Spectroscopy studies reveal that the initial formation of 
the protein corona upon introduction to cell culture media may be responsible for the differences in 
particle-cell interaction. Modeling of particle deposition using the in vitro sedimentation, diffusion and 
dosimetry model helped to clarify what particle phenomena may be occurring at the cellular interface. 
We found that particle administration method in vitro has an effect on particle-cell interactions (i.e. 
cellular adsorption and uptake). Initial introduction of particles in to complex biological media has a 
lasting effect on the formation of the protein corona, which in turn mediates particle-cell interaction. 
It is of note that a minor detail, the way in which we administer particles in cell culture, can have a 
significant effect on what we observe regarding particle interactions in vitro.
!e increasing use of engineered nanomaterials in consumer products, development as diagnostic tools and ther-
apeutic vectors, and growing awareness regarding nano-sized pollutants and environmental toxicology has led to 
a signi"cant push in nanoscience research. Despite the proli"c research output, in particular in the "elds of nano-
medicine and nanotoxicology, there has been mixed success translating biomedical nanoparticles (NPs) from the 
lab into the clinic1–5. !e challenges in bridging the gap between bench-top work and clinical success may stem 
from di#culty in conducting large-scale synthesis of NPs, our limited understanding of fundamental bio-nano 
interactions, lack of worldwide standardization in the "eld regarding NP characterization and biological assays, 
and widespread inter-laboratory di$erences in techniques and methodology leading to di#culty reproducing 
work6–8. Furthermore, variation in experimental design, protocols, controls, and execution may in%uence exper-
imental outcomes and hinder inter-laboratory reproducibility.
As a prominent example of the di#culty in standardizing experiments where nanoparticles-cell interactions 
are addressed, we investigated whether in vitro administration, i.e., the literal way in which researchers add NPs 
to cells, in%uenced the outcome of NP-cell interaction studies (i.e. NP uptake and adsorption to the cell surface). 
Particle administration could in%uence a number of factors such as the local environment around NPs, the dis-
tribution of NPs within the experimental media. It is therefore expected that the way in which NPs are adminis-
tered (e.g. as a homogeneous suspension or as a concentrated bolus) would in%uence particle-cell interactions. 
Moreover, this could in%uence inter-particle interactions, NP colloidal stability, or protein adsorption.
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Rapid and speci!c detection of cell-derived
microvesicles using a magnetoresistive biochip†
Solène Cherré,a Elisabete Fernandes,*b José Germano,c Tomás Dias,c,d
Susana Cardoso,c,d Moisés S. Piedade,c,e Noemi Rozlosnik,a Marta I. Oliveira*b and
Paulo P. Freitasb
Microvesicles (MVs) are a promising source of diagnostic biomarkers which have gained a wide interest in
the biomedical and biosensing !eld. They can be interpreted as a “!ngerprint” of various diseases.
Nonetheless, MVs implementation into clinical settings has been hampered by the lack of technologies to
accurately characterize, detect and quantify them. Here, we report the speci!c sensing and quanti!cation
of MVs from endothelial cells using a portable magnetoresistive (MR) biochip platform, in less than one
hour and within physiologically relevant concentrations (1 ! 108 MVs per ml). MVs were isolated from
both endothelial and epithelial cells undergoing apoptosis, and characterized by atomic force microscopy
(AFM) and nanoparticle tracking analysis (NTA), which revealed similar MV sizes. Importantly, our results
showed that the two distinct MV populations could be discriminated with the MR biochip platform, with
over a 5-fold capture e"ciency of endothelial MVs in comparison to the control (epithelial MVs). Also,
unspeci!c binding of MVs to BSA was less than 1% of the speci!c signal. The detection strategy was based
on a sandwich immunoassay, where MVs were labelled with magnetic nanoparticles (MNPs) function-
alized with Annexin V and then captured by anti-CD31 antibodies previously immobilized on the surface
of the sensor. Results suggest that this approach allows the detection of speci!c MVs from complex
samples such as serum, and highlight the potential of this technology to become a suitable tool for MVs
detection as a complementary method of diagnosis.
1. Introduction
Microvesicles (MVs) are one type of extracellular vesicles
released by blebbing of the cell membrane ranging from 50 to
1000 nm in diameter,1 and they are present in blood2 as well
as in other body fluids, such as urine3 and saliva.4 MVs carry
on their surface the same markers as their cell of origin.5
Moreover, di!erent studies have shown that the number of
circulating MVs varies in certain disease states. Therefore, MVs
have been proposed as novel diagnostic biomarkers for several
pathologies such as cardiovascular diseases,6 autoimmune
diseases7 and cancer.8 Yet, the implementation of MVs as a
diagnostic and prognostic tool has been hampered by the lack
of highly reliable, sensitive characterization and quantification
techniques. In addition, in a clinical setting fast results are
also required.
Currently, MVs are measured by a wide range of methods.9
Flow cytometry, for example, is extensively used in MV
research, even though it is more suitable for biological entities
larger than 200–300 nm. To meet the challenges of measuring
the small sizes of MVs, novel approaches and improved
protocols are being proposed.10,11 Various imaging techniques
such as electron microscopy12,13 or atomic force microscopy
(AFM)14,15 provide an accurate sizing of MVs. However, those
methods are time consuming and require experienced users.
Other sizing approaches include light scattering techniques
such as dynamic light scattering16 and nanoparticle tracking
analysis (NTA),17 as well as resistive pulse sensing.18 Yet, these
still require standardization of the protocols17 and careful
interpretation of the data.19
The protein content of MVs can be analysed using
proteomic techniques.20,21 On the other hand, the frequently
employed capture-based assays22 allow determination of the
pro-coagulant activity of MVs or their cell-specific origin,23 but
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